GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Deferred Policy Acquisition Costs

PharmaLundensis AB (XSAT:PHAL) Deferred Policy Acquisition Costs


View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


PharmaLundensis AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.